Gary Egan

Distinguished Professor and Foundation Director of Monash Biomedical Imaging

Data updated

Papers

7 publications

Trials

0 clinical trials

Links

Research Footprint

Gary Egan appears in 7 tracked papers (2021–2025), most studied alongside Psilocybin and LSD, across Neuroimaging & Brain Measures, Healthy Volunteers and Depressive Disorders.

Most-cited paper: Effective connectivity of functionally anticorrelated networks under LSD (47 citations).

Frequent co-authors: Adeel Razi, Devon Stoliker and Katrin Preller.

Background & Research

Gary F. Egan is a neuroscientist and neuroimaging researcher at Monash University, where he serves as Foundation Director of Monash Biomedical Imaging and a Distinguished Professor in the Turner Institute for Brain and Mental Health. His broader career spans PET/MRI and brain-function research, and he has published extensively in neuroscience and medical imaging. He has recently coauthored multiple influential psychedelic neuroimaging papers on psilocybin and LSD.

Key Impact

He is a leading neuroimaging researcher whose work has helped elucidate the brain mechanisms of psychedelics, including psilocybin- and LSD-related changes in connectivity, ego dissolution, and visual imagery.

7

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

13 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Gary Egan is associated with.